Quick Order Cart

Cat. No. ARG39328

DNAJC6 Knockout K562 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Pleural effusion

  • Disease:

    Chronic myeloid leukemia

DNAJC6 Knockout K-562 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the human chronic myelogenous leukemia K-562 cell line. This model disrupts DNAJC6, which encodes auxilin, a co-chaperone that recruits Hsc70 (HSPA8) to disassemble clathrin-coated vesicles during endocytosis. Auxilin dysfunction is implicated in Parkinson??s disease, and knockout impairs clathrin-mediated endocytosis and synaptic vesicle recycling. In K-562 cells, it provides a tractable system to study receptor internalization, membrane trafficking, and endocytosis-dependent signaling. Applications include transferrin uptake assays, co-immunoprecipitation, and drug screening.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    K562

    Sex of Donor

    Female

    Derived From Site

    In situ; Pleural effusion

    Gene Name

    DNAJC6

    Gene Identifier

    NCBI Gene ID 9829

    Growth Mode

    Suspension

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DNAJC6 Knockout K-562 Polyclonal Cells are a polyclonal knockout cell population generated by CRISPR/Cas9-mediated disruption of the DNAJC6 gene in the human K-562 cell line. This product provides a genetically heterogeneous pool of cells carrying targeted gene disruptions, enabling loss-of-function studies without clonal selection. The knockout model allows researchers to investigate the functional consequences of DNAJC6 ablation in a cellular context amenable to high-throughput assays and suspension culture. It is designed for applications requiring robust endocytosis models free from the complexities of neuronal systems.

K-562 cells are a widely characterized human chronic myelogenous leukemia (CML) cell line originally established from the pleural effusion of a patient in blast crisis. These cells are undifferentiated, multipotent progenitors capable of differentiating along erythroid, granulocytic, and monocytic lineages under appropriate stimuli. As a suspension cell line, K-562 offers high reproducibility and scalability for biochemical experiments, flow cytometry, and live-cell imaging. Its well-documented genetic background and robust growth make it an ideal host for studying clathrin-mediated endocytosis and receptor trafficking in a hematopoietic context.

DNAJC6 encodes auxilin, a J-domain co-chaperone that specifically recruits heat shock cognate 70 (Hsc70/HSPA8) to clathrin-coated vesicles. By stimulating Hsc70??s ATPase activity, auxilin drives the dissociation of the clathrin lattice, a critical step in vesicle uncoating and cargo internalization. Auxilin functions downstream of neuronal activity and is regulated by transcription factors such as SP1 and CREB. It interacts directly with the clathrin heavy chain (CLTC), the AP2 adaptor complex (including AP2A1 and AP2M1), and the GTPase dynamin (DNM1). Disruption of DNAJC6 impairs clathrin-mediated endocytosis and synaptic vesicle recycling, linking auxilin dysfunction to neurodegenerative disorders like Parkinson??s disease.

In the K-562 cell model, DNAJC6 knockout disrupts the normal endocytic machinery, offering a simplified system to dissect clathrin-dependent internalization pathways without neuronal synaptic specialization. Although K-562 cells lack synaptic vesicles, they express all necessary components for clathrin-mediated endocytosis, including CLTC, AP2A1, HSPA8, and DNM1. This knockout model thus enables the study of auxilin??s role in general endocytic processes, such as transferrin receptor uptake, growth factor signaling, and immune receptor internalization. Additionally, it serves as a valuable platform for investigating how impaired endocytosis may contribute to leukemia cell biology or for comparative analyses with Parkinson??s disease-related neurodegeneration.

Researchers can employ this polyclonal knockout population in a variety of assays, including western blotting and RT-qPCR to confirm gene disruption, immunofluorescence to visualize clathrin coat accumulation, and transferrin uptake assays to quantify endocytosis defects. Co-immunoprecipitation experiments can assess altered interactions between auxilin and its partners, while flow cytometry can monitor surface receptor dynamics. This model is particularly suited for drug discovery screens targeting endocytosis modulators, high-content imaging of vesicle trafficking, and functional complementation studies. For further technical details or to discuss customization options, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)